Medigen Biotechnology Corp. (TPEX:3176)
35.50
+0.75 (2.16%)
Oct 16, 2026, 1:30 PM CST
| Market Cap | 4.95B +21.6% |
| Revenue (ttm) | 1.27B -22.0% |
| Net Income | -252.36M |
| EPS | -1.81 |
| Shares Out | 139.31M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 270,887 |
| Open | 34.85 |
| Previous Close | 34.75 |
| Day's Range | 34.85 - 35.85 |
| 52-Week Range | 28.20 - 43.60 |
| Beta | 0.30 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 12, 2026 |